云南高校图书馆联盟文献共享服务平台- Oncology and Translational Medicine

《Oncology and Translational Medicine》: 作品数：484被引量：279H指数：5; 导出分析报告; 主办单位：华中科技大学同济医学院; 最新期次：2025年2期更多>>; 发文主题：CANCERPROGNOSISCASE_REPORTONCOLOGYBREAST_CANCER更多>>; 发文领域：医药卫生自动化与计算机技术历史地理一般工业技术更多>>; 发文基金：国家自然科学基金湖北省自然科学基金中国博士后科学基金国家重点基础研究发展计划更多>>

Integration and innovative development of enhanced recovery after surgery and anesthesiology.Enhanced recovery after surgery and rational use of opioids: 《Oncology and Translational Medicine》2025年第2期47-49,共3页Chengye Yao Bingqing Nie Shanglong Yao; 1.The development history of enhanced recovery after surgery(ERAS)Enhanced recovery after surgery(ERAS)is a multimodal perioperative care approach that has evolved over the past 2 decades since its inception.In 1997,P...; 关键词：ERAS enhanced recovery surgery multimodal perioperative care approach OPIOID enhanced recovery surgery eras enhanced recovery surgery eras multimodal perioperative care colorectal surgery colorectal surgerysubsequentlythe

Prevalence and genotype distribution of human papillomavirus among women with cervical or vaginal lesions in Jiangsu,China:2 cross-sectional studies(2012–2013 and 2020–2021): 《Oncology and Translational Medicine》2025年第2期50-57,共8页Weiwei Han Wenjuan Wang Kai Chu Zhaofeng Bi Qi Chen Jingxin Li Fengcai Zhu; supported by Xiamen University,which played a key role in the collection and analysis of the data;funded by National Natural Science Foundation of China(grants 82341031,82173584,and 82222062);Major Research Plan of the National Natural Science Foundation of China(grant 92269205);Science Fund for Distinguished Young Scholars of Jiangsu Province(grant BK20220064);Jiangsu Provincial Key Project of Science and Technology Plan(grants BE2021738 and BE2023601)。; Background:Human papillomavirus(HPV)infection is a major risk factor of cervical cancer.This study assessed the prevalence and distribution of HPV genotypes in women with cervical or vaginal lesions in Jiangsu Provinc...; 关键词：Cervical lesion Genotype distribution Human papillomavirus Jiangsu Province PREVALENCE Vaginal lesion

Berberine restrained proliferation,invasion,and migration by targeting the glycogen synthase kinase 3β/β-catenin pathway in lung adenocarcinoma cells: 《Oncology and Translational Medicine》2025年第2期58-72,共15页Tenzin Wangmu Chenlu Li Guangsu Han Ping Yi; Supported by a grant from the National Natural Science Foundation of China(no.82174457)。; Background:Lung cancer is one of the deadliest cancers worldwide,creating a pressing need to develop novel drugs that inhibit oncogenic signaling pathways.Numerous studies have shown that berberine(BBR)has anti–lung ...; 关键词：BERBERINE Glycogen synthase kinase 3β Lung adenocarcinoma Non‐small cell lung cancer Β-CATENIN

Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients: 《Oncology and Translational Medicine》2025年第2期73-80,共8页Ran Feng Lihui Pan Yarong Yao Jinnan Gao Xiaojun Zhang; supported by grants from the Basic Research Project of Shanxi Science and Technology Department(no.202303021221190);the Shanxi General Surgery“136”Healthcare Engineering Project(no.2024XYZ03)。; Background:This study assessed the frequency of changes in some key receptor status of tumors after neoadjuvant chemotherapy(NAC)in patients with invasive breast cancer and the prognostic impact of these changes.Metho...; 关键词：Neoadjuvant chemotherapy Breast cancer Receptor conversions DISCORDANCE Prognostic impact

Advances in immunotherapy and targeted therapy for pancreatic cancer: 《Oncology and Translational Medicine》2025年第2期81-91,共11页Xiangyan Zhou Xiaohui Wang Shengli Yang Zaozao Huang; Pancreatic cancer remains one of the most challenging malignancies to treat,with a poor prognosis and limited therapeutic options.Despite the success of immunotherapy and targeted therapies for other cancers,these app...; 关键词：Pancreatic cancer IMMUNOTHERAPY Targeted therapies

Oncology and Translational Medicine Editorial Board: 《Oncology and Translational Medicine》2025年第2期I0001-I0002,共2页

Pan-cancer transcriptomic analysis reveals HSPB8 as a prognostic and immunological biomarker in colorectal cancer: 《Oncology and Translational Medicine》2025年第1期36-45,共10页Yuyong Deng Xuguang Sun Rui Jian DuojiaWu Junyang Wang Shan Li; supported by the NationalNatural Science Foundation of China(no.32360888);the Jiangxi Students’Platform for Innovation and Entrepreneurship Training Program(no.202411843023).; Background:Heat shock protein B8(HSPB8)is implicated in autophagy,and its aberrant expression has been linked to both the ini-tiation and progression of tumors.However,the role and function of HSPB8 in colorectal canc...; 关键词：BIOMARKER Differentially expressed gene HSPB8 Immune infiltration Pan-cancer

Oncology and Translational Medicine Editorial Board: 《Oncology and Translational Medicine》2025年第1期I0001-I0002,共2页

Advances in neoadjuvant therapy for resectable intrahepatic cholangiocarcinoma: An invited commentary: 《Oncology and Translational Medicine》2025年第1期1-4,共4页Ruyu Han Peipei Song Wei Tang Tianqiang Song Lu Chen; supported by the National Natural Science Foundation of China(grants 82373365 and 82173317);the Tianjin Key Medical Discipline Construction Project(TJYXZDXK-009A).; Intrahepatic cholangiocarcinoma(ICC)poses a significant threat to human health owing to its high malignancy rate and poor prognosis.Sur-gery is the most effective treatment option for ICC.However,the prognosis remains...; 关键词：Intrahepatic cholangiocarcinoma Resectable Neoadjuvant therapy

Perspectives on the potential application of microRNAs in the diagnosis and treatment of triple-negative breast cancer: 《Oncology and Translational Medicine》2025年第1期5-9,共5页Yeqin Wu Haitao Song Huifang Shi Gangping Wang; supported by Shandong Provincial Natural Science Foundation(no.ZR2020MH319).; Triple-negative breast cancer(TNBC)is currently the most heterogeneous and aggressive breast cancer type.It has a high recurrence rate,poor clinical prospects,and lack of predictive markers and potential treatment opt...; 关键词：Triple-negative breast cancer MIRNA oncomiRs TUMORIGENESIS PROGNOSIS Chemotherapy resistance

《Oncology and Translational Medicine》